TABLE 2.
Pretreatment | Rituximab | 375 mg/m2 IV |
Day1, 4, 7, 11 | Plasmapheresis | |
Methylprednisolone | 5 mg/kg (max 100 mg) | |
Bortezomib | 1.3 mg/m2 IV | |
Day14–16 | Plasmapheresis | |
Day 18 | PRA, T-/B-cell subsets | |
Follow-up after 30 Days | PRA, T-/B-cell subsets |
PRA, panel reactive antibody.